---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-046481"
form_type: "8-K"
ticker: "SNWV"
cik: "0001417663"
company_name: "SANUWAVE Health, Inc."
filed_at: "2024-11-08T23:59:59+00:00"
generated_at: "2026-05-30T02:45:44.819576+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.82
calibrated_materiality_score: 0.82
confidence: "high"
source: SEC EDGAR
---

# SANUWAVE Q3 revenue $9.4M (+89% YoY), operating income $2.0M; Q4 guidance 40-50% growth

## Summary
- Revenue record of $9.4M, up 89% vs Q3 2023; beat guidance of 65-75% increase.
- UltraMist systems sold: 124 in Q3 2024 vs 55 in Q3 2023; consumables revenue $5.4M (+75%).
- GAAP operating income $2.0M vs loss of $0.5M in Q3 2023; Adj. EBITDA $2.1M vs ($0.3M).
- Net loss $20.7M (driven by derivative liability fair value change); year-to-date loss $18.6M.
- Guides Q4 2024 revenue $9.7-10.5M (+40-50% YoY); FY2024 revenue >$32M; 1-for-375 reverse split Oct 18.

## SEC filing metadata
- accession: 0001628280-24-046481
- form_type: 8-K
- ticker: SNWV
- cik: 0001417663
- company_name: SANUWAVE Health, Inc.
- filed_at: 2024-11-08T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.82
- calibrated_materiality_score: 0.82
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1417663/000162828024046481/0001628280-24-046481-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1417663/000162828024046481/snwv-20241108.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-046481
- JSON: https://secwatch.observer/filing/0001628280-24-046481.json
- Plain text: https://secwatch.observer/filing/0001628280-24-046481.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.